They may be prescribed when medically appropriate and prepared by licensed, FDA-compliant compounding pharmacies that follow applicable state and federal standards
Treatment begins at the lowest dose with gradual escalation every four weeks to minimize gastrointestinal adverse effects such as nausea, vomiting, and diarrhea
The procedure is completed through radiation therapy to ensure minimum relapse
However, a common frustration for many health-conscious individuals is the conflicting information regarding its efficacy
According to a 2024 poll, the number of people in the United States who started using GLP-1 agonists for weight loss has increased by 700-fold in just four years from 2019 to 2023
Manish Sahni, MD, at Centra Internal Medicine The FDA clearance of oral semaglutide introduces the first pill-based GLP-1 option for weight loss, offering patients an alternative to injectable treatments